CADTH Drug Portfolio Information Session

Here’s an opportunity for all interested stakeholders to get the latest information about priority initiatives and process changes from the CADTH pharmaceutical reviews portfolio.

Thursday, November 26, 2020
9:00am – 12:00pm EST

The session includes an open forum, where attendees can direct questions to CADTH President and CEO Suzanne McGurn and other senior staff at CADTH. Advance registration required.